Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review-Reference-Cited by-同舟云学术

Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review

Published:2022-11-25 Issue:1 Volume:13 Page:77-94
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Mital Rohan^ORCID,Gray Ashley,Minta Abena,Almhana Farah,Amin Sabrina,Hydol-Smith Jourdan,Mallela Teja,Kaffenberger Benjamin H.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-022-00860-5.pdf

Reference88 articles.

1. Kamata M, Tada Y. Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: a literature review. Int J Mol Sci. 2020;21(5):E1690. https://doi.org/10.3390/ijms21051690.

2. Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029–72. https://doi.org/10.1016/j.jaad.2018.11.057.

3. Yao Y, Thomsen SF. The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa. Dermatol Online J. 2017;23(7):13030/qt8rw2j9zv.

4. Reardon K, Levin J, Levin C. Severe hidradenitis suppurativa with herpes simplex virus 1 superinfection and clinical responsiveness to ixekizumab. JAAD Case Rep. 2021;9:7–8. https://doi.org/10.1016/j.jdcr.2020.12.036.

5. Megna M, Ruggiero A, Di Guida A, Patrì A, Fabbrocini G, Marasca C. Ixekizumab: an efficacious treatment for both psoriasis and hidradenitis suppurativa. Dermatol Ther. 2020;33(4): e13756. https://doi.org/10.1111/dth.13756.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinical Characteristics of Patients With Pyoderma Gangrenosum in a Tertiary Referral Hospital: A Retrospective Cohort Study;The International Journal of Lower Extremity Wounds;2023-09-12

2. Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs;Clinical, Cosmetic and Investigational Dermatology;2023-08

3. A Case Report and Literature Review of the Role of Dupilumab in the Management of Lichen Planus: Cause or Treatment?;Cureus;2023-07-02